MECP2 Rett MBD–DNA campaign
Aug 2025 Labs/MECP2. 16 Sep 2026 README: further testing did not support the findings; lab materials withdrawn. Do not rely on them as validation. Restricted/Corrected.
Applied · Applied · Corrected · 2026-09-19 · compiled 2026-10-10 · 3 min read · 2 claims
Package: Labs/MECP2 · JSON · Cite
protein · MECP2 · Rett · R106W · R133C
On this page
Causal stack
- 00 Astra / global consistency
- 01 Genesis Pin
- 02 Retained pruning-order history
- 03 Admissible slice
- 04 L1 (closed)
- 05 L2 (closed)
- 06 L3 hyperedge memory T_H + D_L3
- 07 L4 H₄ rank lift
- 08 Discrete atlas / scalar accessibility
- 09 GEM-bridge / gravity
Labs/MECP2 is a 19-run campaign on the methyl-CpG-binding domain of MeCP2, dated 26–28 Aug 2025. The contract is findings.json v3.3. The human abstract (abstract.txt) is titled Computational Audit and Verification of a Rescue Strategy for Rett Syndrome-Associated MECP2 Mutations and is attributed to “The Gemini Auditing Group.” There is no load-bearing X field note for this campaign in the current compile. Cite GitHub.
Audit honesty is the load-bearing part
The engine’s own abstract reports 15 CONFIRMED, 1 DEVIATION, 3 INDETERMINATE. Isolated-MBD baselines (Runs 1–3) are INDETERMINATE because diagnostics_timeseries.csv is missing. Run 5 (unrescued R106W–DNA) was contracted as unstable (RMSD ≥ 20 Å) and the definitive tail median came back 3.06 Å — DEVIATION, not a quiet pass. Do not cite this campaign as 19/19 clean. This compile independently reproduced those three counts from the bound CSVs on 7 Sep 2026. Start there: Run this first on the WetLabEngine protein audit page.
Thesis in the contract
MECP2 MBD Rett mutations destabilize DNA binding but can be rescued by stabilizing the encounter complex; WT complex is inherently stable.
Machine test: count_runs_meeting where best_final_RMSD_A ≤ 4.5 must be ≥ 3. The audit abstract says 16 runs met that cutoff, so the thesis constraint passed. Passing a count constraint is not a therapeutic claim.
Campaign map
| Runs | Role | Posted outcome | Cite as |
|---|---|---|---|
| 1–3 | Full-length WT; isolated WT MBD; isolated R106W MBD (no DNA) | INDETERMINATE (missing diagnostics CSV). Secondary RMSD ~51 Å (IDP-like FL) and ~14.4 Å (isolated MBD). | Missing primary data, not a hidden fail. |
| 4 | WT MBD–DNA gold-standard complex | CONFIRMED. Definitive RMSD 3.06 Å. | Positive control. |
| 5 | Unrescued R106W MBD–DNA | DEVIATION. Contract required ≥ 20 Å; data 3.06 Å. | The campaign’s own mismatch. RMSD can lie. |
| 6–9 | InterfaceAnneal on R106W, R133C, WT | CONFIRMED near-native (≤ 4.0 Å + 0.5 Å tolerance). Generalizes across two Rett mutations. | Restricted protocol success inside this model. |
| 10–13 | Post-anneal challenge (R106W, R133C, WT ×2) | CONFIRMED RMSD ≤ 6.0. Rescued states held under challenge. | Kinetic robustness in-silico, not cellular. |
| 14–16 | ElecTuning / AutoAnneal | CONFIRMED protocol-optimization band (≤ 6.0 Å). | Parameter sweep, not a new mechanism. |
| 17–19 | Recovery Pocket; salt/pH challenge ×2 | CONFIRMED ≤ 6.0 Å. | Pocket and salt/pH levers inside the same force field. |
Verdict language from Labs/MECP2/abstract.txt, which reports the v5.1 engine pass. PNG/PDB artifacts are Git LFS; reports and findings.json are ordinary files.
What a researcher should not write
- Do not write “MECP2 folding is solved.” Full-length WT is treated as IDP-like; the campaign is about the MBD–DNA interface.
- Do not write “R106W is unstable because RMSD is high.” Run 5 is the counterexample: a low RMSD that failed the instability claim.
- Do not write “interface annealing is a Rett therapy.” It is an in-silico protocol that seated mutant complexes in this coarse-grained model.
- Do not promote the thesis implications (ligand-design avenues, generalizable rescue) to Supported. They are manuscript discussion, Restricted at most.
Restricted
Inside this 19-run coarse-grained campaign, InterfaceAnneal seated R106W and R133C MBD–DNA complexes to near-native RMSD, and post-anneal challenges held. The WT–DNA complex is a stable positive control. This is not a Rett therapy, not all-atom MD, and not a folding oracle.
Restricted
Run 5 is a recorded DEVIATION: the unrescued-mutant contract (RMSD ≥ 20 Å) did not match the definitive 3.06 Å tail. Runs 1–3 are INDETERMINATE for missing diagnostics CSV. Cite the mismatch; do not drop it.
- Labs/MECP2 on GitHub
- findings.json v3.3
- Run this first (deterministic smoke)
- Auditor script
- p53 campaign
Previous WetLabEngine protein auditNext p53 mutational mechanisms
Causal stack
- 00 Astra / global consistency
- 01 Genesis Pin
- 02 Retained pruning-order history
- 03 Admissible slice
- 04 L1 (closed)
- 05 L2 (closed)
- 06 L3 hyperedge memory T_H + D_L3
- 07 L4 H₄ rank lift
- 08 Discrete atlas / scalar accessibility
- 09 GEM-bridge / gravity
On this page
Related articles
- For researchers and models
- Claim ledger
- Applied recoverability stack
- WetLabEngine protein audit
- p53 mutational mechanisms
- Frozen v9 protein bridge (1UAO / 1L2Y)
- Open science method
GitHub packages